The Discounted Cash Flow (DCF) valuation of Johnson & Johnson (JNJ) is 159.57 USD. With the latest stock price at 152.49 USD, the upside of Johnson & Johnson based on DCF is 4.6%.
Based on the latest price of 152.49 USD and our DCF valuation, Johnson & Johnson (JNJ) is a buy. buying JNJ stocks now will result in a potential gain of 4.6%.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 7.7% | 6.8% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 106.28 - 320.02 | 159.57 |
| Upside | -30.3% - 109.9% | 4.6% |